Return to Vaccination News Home Page

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Search This Site using keywords

http://pediatrics.aappublications.org/cgi/content/abstract/111/6/S2/1601

Pediatrics AAP Policy
Home Help [Feedback] [For Subscribers] [Browse & Search]


Full Text of this Article
Reprint (PDF) Version of this Article
Email this article to a friend
P3Rs: Submit a response to this article
Similar articles found in:
Pediatrics Online
Search PubMed for articles by:
Sampson, H. A.
Alert me when:
new articles cite this article
 
Download to Citation Manager
Collections under which this article appears:
Allergy & Dermatology
 


PEDIATRICS Vol. 111 No. 6 June 2003, pp. 1601-1608

 

Anaphylaxis and Emergency Treatment

Hugh A. Sampson, MD

 

From the Elliot and Roslyn Jaffe Food Allergy Institute, Division of Allergy and Immunology, Department of Pediatrics, Mount Sinai School of Medicine, New York, New York

Food anaphylaxis is now the leading known cause of anaphylactic reactions treated in emergency departments in the United States. It is estimated that there are 30 000 anaphylactic reactions to foods treated in emergency departments and 150 to 200 deaths each year. Peanuts, tree nuts, fish, and shellfish account for most severe food anaphylactic reactions. Although clearly a form of immunoglobulin E-mediated hypersensitivity, the mechanistic details responsible for symptoms of food-induced anaphylaxis are not completely understood, and in some cases, symptoms are not seen unless the patient exercises within a few hours of the ingestion. At the present time, the mainstays of therapy include educating patients and their caregivers to strictly avoid food allergens, to recognize early symptoms of anaphylaxis, and to self-administer injectable epinephrine. However, clinical trials are now under way for the treatment of patients with peanut anaphylaxis using recombinant humanized anti-immunoglobulin E antibody therapy, and novel immunomodulatory therapies are being tested in animal models of peanut-induced anaphylaxis.

 

Key Words: anaphylaxis • immunoglobulin E • anti-IgE antibodies • food hypersensitivity • elimination diet • EpiPen

 

Abbreviations: IgE, immunoglobulin E

 


Received for publication Sep 11, 2002; accepted Oct 30, 2002.

 

[For Subscribers]
Copyright © 2003 by the American Academy of Pediatrics. [Disclaimer]

 

 

 

Return to Vaccination News Home Page

DISCLAIMER:    All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice.  The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.